The Effect of a Cyclooxygenase-2 Inhibitor on Proliferating Activity in Breast Cancer: First Results

Publisher： Karger

E-ISSN： 1661-3805|1|5|320-323

ISSN： 1661-3791

Source： Breast Care, Vol.1, Iss.5, 2006-10, pp. : 320-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

By  

Breast Care, Vol. 11, Iss. 3, 2016-06 ,pp. : 174-176

Karger

Access to resources Recommend Favorite

Disease Management Program Breast Cancer – First Experience

By  

Breast Care, Vol. 1, Iss. 3, 2006-07 ,pp. : 152-156

Karger

Access to resources Recommend Favorite

The Role of Physical Activity in the Prevention and Rehabilitation of Breast Cancer

By  

Breast Care, Vol. 1, Iss. 5, 2006-10 ,pp. : 310-314

Karger

Access to resources Recommend Favorite

Correlation of Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesterone Receptor (PR) Expression as Predicted by Core Biopsy with the Immunohistochemical Results of Surgical Breast Cancer Specimens

By  

Breast Care, Vol. 2, Iss. 2, 2007-04 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

HER2 Testing in Breast Cancer: Opportunities and Challenges

By  

Breast Care, Vol. 1, Iss. 2, 2006-05 ,pp. : 69-76

Karger

Access to resources Recommend Favorite